ANEXIGEN
Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. The company's platform has the potential to identify novel antibacterial agents with activity against drug-resistant bacteria of biomedical interest and enables functional screening of DNA-encoded peptide-based libraries directly on any Gram-negative pathogen to identify novel antibiotic chemical scaffolds, enabling clinicians and patients to defeat drug-resistant pathogens with the power of Surface Localized Antimicrobial Display (SLAY) platform.
ANEXIGEN
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
Correlation Ventures
Correlation Ventures investment in Venture Round - Anexigen